Trinity Biotech plc to Host Investor Call
January 30 2024 - 5:23PM
Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading
developer and manufacturer of diagnostic solutions for the
point-of-care and clinical laboratory markets, will host an
investor call on Wednesday, January 31 at 8:30 AM ET to provide an
update on business operations.
Conference Call Dial-In & Webcast
Information
|
Date: |
Wednesday, January 31, 2024 |
| Time: |
8:30 AM ET |
| United States: |
1-877-407-0784 |
| International: |
1-201-689-8560 |
| Conference ID: |
13744109 |
| Webcast: |
Click Here for Webcast |
| CallMe™: |
Click Here for CallMe
Feature |
About Trinity Biotech Trinity Biotech develops,
acquires, manufactures and markets diagnostic systems, including
both reagents and instrumentation, for the point-of-care and
clinical laboratory segments of the diagnostic market. The products
are used to detect infectious diseases and to quantify the level of
Haemoglobin A1c and other chemistry parameters in serum, plasma and
whole blood. Trinity Biotech sells direct in the United States,
Germany, France and the U.K. and through a network of international
distributors and strategic partners in over 75 countries worldwide.
For further information, please see the Company's website:
www.trinitybiotech.com.
|
Contact: |
Trinity Biotech plcDes
Fitzgerald(353)-1-2769800 |
LifeSci Partners, LLCEric
Ribner(1)-646-751-4363E-mail
investorrelations@trinitybiotech.com |
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Apr 2023 to Apr 2024
